Variable | Total cost, mean, $ | p value | Multivariable adjusted regression coefficient, $ (95% CI) | p value |
---|---|---|---|---|
Age, yr | ||||
< 56 | 29 132 | < 0.01 | 0 (ref.) | |
56–65 | 30 475 | 1385 (996 to 1775) | < 0.01 | |
66–75 | 31 849 | 1057 (659 to 1455) | < 0.01 | |
≥ 76 | 31 837 | −1024 (−1482 to −565) | < 0.01 | |
Gender | ||||
Female | 29 514 | < 0.01 | 0 (ref.) | |
Male | 32 323 | 5195 (4799 to 5591) | < 0.01 | |
Charlson Comorbidity Index score | ||||
0 | 23 611 | < 0.01 | 0 (ref.) | |
1 | 28 163 | 4186 (3507 to 4865) | < 0.01 | |
≥ 2 | 41 404 | 16 961 (16 595 to 17 326) | < 0.01 | |
No Score | 20 874 | −3464 (−3867 to −3060) | < 0.01 | |
Cancer site | ||||
Breast | 29 897 | < 0.01 | 0 (ref.) | |
Lung | 40 748 | −142 (−835 to 551) | 0.69 | |
Prostate | 18 812 | −19 066 (−19 748 to −18 385) | < 0.01 | |
Genitourinary | 27 572 | −11 787 (−12 390 to −11 184) | < 0.01 | |
Gastrointestinal | 38 649 | −3946 (−4483 to −3410) | < 0.01 | |
Gynaecological | 25 592 | −9293 (−9850 to −8736) | < 0.01 | |
Other | 31 477 | −142 (−5481 to −4546) | < 0.01 | |
Income quintile | ||||
Quintile 1 (lowest) | 32 632 | < 0.01 | 0 (ref.) | |
2 | 31 000 | −857 (−1318 to −396) | < 0.01 | |
3 | 30 515 | −1081 (−1538 to −624) | < 0.01 | |
4 | 29 800 | −1610 (−2074 to −1146) | < 0.01 | |
Quintile 5 (highest) | 29 396 | −1737 (−2196 to −1279) | < 0.01 | |
LHIN region | ||||
Toronto | 35 849 | < 0.01 | 0 (ref.) | |
West | 30 667 | −5572 (−5989 to −5155) | < 0.01 | |
Central | 27 565 | −8182 (−8630 to −7734) | < 0.01 | |
East | 28 138 | −7593 (−8038 to −7148) | < 0.01 | |
North | 32 421 | −5725 (−6418 to −5031) | < 0.01 | |
Cohort | ||||
Control | 30 573 | < 0.01 | 0 (ref.) | |
Cancelled | 35 568 | 1100 (3 to 2196) | 0.049 |
CI = confidence interval; LHIN = Local Health Integration Network; ref. = reference.